Explore the intricacies of the FDA's new classification for DNA-based tests measuring minimal residual disease in hematological malignancies. Learn how the shift to Class II with special controls impacts safety, effectiveness, and patient access, reducing regulatory...
Government and Regulatory Affairs
Showing 37–45 of 736 resultsSorted by latest
-
FAA Rule: Flight Prohibition Over Libyan Airspace
$49.99 -
Patient Protection and Affordable Care Act: Proposed Marketplace Rule Analysis
$199.99 -
FAA Proposed Rule: Enhancing Lightning Strike Safety on Airbus A350
$9.99 -
FAA Airworthiness Directive Compliance for Airbus A300-600
$9.99 -
US Swine Health Improvement Plan: Comprehensive Certification Course
$49.99 -
USDA Multifamily Housing Credit Report Process Update
$9.99 -
Updated ‘Healthy’ Definition for Food Labeling by FDA
$199.99 -
Compliance with Select Agent Regulations for Junín Virus Vaccine
$9.99 -
Privacy Act Exemptions for ORR Records
$9.99